|Ms. Laura A. Francis MBA||CEO & Director||879.74k||N/A||1967|
|Mr. Anshul Maheshwari||Chief Financial Officer||511.05k||N/A||1978|
|Mr. Anthony J. Recupero||Pres of Commercial Operations||665.91k||N/A||1959|
|Mr. Michael A. Pisetsky||Sr. VP of Operations & Admin., Sec. and Chief Legal Officer||N/A||N/A||1978|
|Dr. Scott A. Yerby||Sr. VP of Engineering & CTO||N/A||N/A||1968|
|Mr. Joseph W. Powers||VP of Corp. Marketing||N/A||N/A||1960|
|Dr. Daniel Joseph Cher||Sr. VP of Clinical & Regulatory Affairs||N/A||N/A||1965|
|Dr. W. Carlton Reckling||Chief Medical Officer & VP of Medical Affairs||N/A||N/A||1962|
|Mr. Nikolas F. Kerr||Sr. VP of Product, Strategy & Bus. Devel.||N/A||N/A||1972|
|Ms. Joyce Goto||VP & Corp. Controller||N/A||N/A||1974|
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
SI-BONE, Inc.’s ISS Governance QualityScore as of May 1, 2022 is 9. The pillar scores are Audit: 3; Board: 7; Shareholder Rights: 8; Compensation: 10.